Supplementary Methods

General
Isotopically-labeled reagents were purchased from Sigma-Aldrich or synthesized as described below. Restriction enzymes and PCR reagents were purchased from New England Biolabs. A standard of dynemicin A was purified from wild-type M. chersina following established procedures with modifications 29, 30 . Mycelial stocks of wild-type M. chersina and gene deletion strains were prepared as described previously 28 . Plasmids were sequenced at The Synthesis & Sequencing Facility at the Johns Hopkins University School of Medicine.
Preparation of wild-type M. chersina for gDNA isolation
A mycelial stock of M. chersina NRRL B-24756 (100 μL) was plated on Bacto 
Isolation of gDNA from wild-type and mutant M. chersina
The gDNA of wild-type M. chersina and CRISPR-Cas9 mutant strains was isolated using modifications of an established protocol 31 . Frozen cell pellet was thawed, washed with 40 mL sterile TES buffer (300 mM sucrose, 25 mM Tris-HCl, 25 mM Na 2 EDTA-2H 2 O, pH 8.0), and re- 
Whole genome sequencing of M. chersina
A gDNA library of M. chersina NRRL B-24756 was prepared using the Illumina® TruSeq® Nano DNA Sample Prep Kit with barcodes. Paired-end 100 bp x 100 bp sequencing of the library was performed using an Illumina® HiSeq2500 in Rapid Run
Mode, producing approximately 40 million reads. BCL files generated by the sequencing were converted to FASTQ files with Illumina®'s CASAVA 1.8.4 using default parameters.
De novo draft assemblies were built from the FASTQ files using SOAPdenovo v2.04 32 and SPAdes v.3.5.0 33 , and the assemblies were finally merged using GAM-NGS v1.1b 34 .
Construction of pCRISPR-Cas9 plasmids
CRISPR-Cas9 gene deletions required the design of a homologous recombination template (HRT) and a single guide RNA (sgRNA) for insertion into the pCRISPR-Cas9 plasmid.
HRTs were ~2.2 kbp long (~1 kbp from each side of the gene being knocked out), and were designed to delete >90% of the coding sequences of the target genes from the genome (between one and five genes were targeted per mutant). Start and stop codons were included in the HRTs when possible so as to not disturb the reading frame of flanking genes. HRTs were PCRamplified in two fragments (a 5' fragment and a 3' fragment with the appropriate 5F, 5R, 3F, and 3R primers in Supplementary 
PCR confirmation of CRISPR-Cas9 gene deletions
To confirm successful deletion of genes targeted by CRISPR-Cas9, PCR reactions were performed in parallel comparing wild-type M. chersina gDNA to that of the various PKS mutant strains. For each gene deletion, PCR primers (denoted "KOtest" in Supplementary Table 4 ) were designed that annealed to the gDNA immediately outside the HRT sequence that was cloned into the pCRISPR-Cas9 plasmid. The primers were used in 25 μL PCR reactions with Phusion® HighFidelity DNA Polymerase with the supplied buffer for GC-rich templates and 10% (v/v) DMSO to maximize primer-annealing specificity. PCR fragments of wild-type versus mutant gDNA were analyzed on 1% agarose gels ( Supplementary Fig. 2 ). To obtain enough DNA for sequencing, the "KOtest" primers were used for a second set of 50 μL PCR reactions (1-2 reactions per mutant).
PCR fragments were purified on 1% agarose gels, extracted using a GeneJET Gel Extraction Kit (Thermo Fisher Scientific), and sequenced.
Small-scale fermentation of CRISPR-Cas9 mutants
Mycelial stocks of CRISPR-Cas9 mutants (100 μL) or spores of wild-type M. chersina (10 μL) were plated on medium 53 28 with 2% agar and incubated at 28 o C. After 4-5 days, the resulting mycelia on agar were inoculated into 50 mL medium 53 in 125 mL flasks. Cultures were shaken at 250 rpm and 28 o C for 7 days, following which 2 mL each were inoculated into 50 mL analyzed on day 7 of the fermentation, as described in the Methods. Intermediates were isolated and analyzed by UPLC-ESI-MS on day 10 of the fermentation, as described below. 
Small-scale isolation and UPLC-ESI-MS analysis of enediyne intermediates produced by
Purification of dynemicin and related biosynthetic intermediates
Large-scale fermentations (2-3 L) were extracted with an equal volume of EtOAc by stirring for 2 h on a magnetic stir plate. The extract was filtered through a bed of Celite in a fritted funnel, and the resulting filtrate was washed with brine, dried with anhydrous sodium sulfate (Na 2 SO 4 ), and concentrated in vacuo. The crude extract was resuspended in ~3 mL EtOAc, and
Celite was added to form a slurry. The solvent was again removed in vacuo, and the Celite was dry-loaded onto a silica flash chromatography column. The column was run with a gradient of 0% -2% -10% methanol (MeOH) in chloroform (CHCl 3 ). The dynemicin complex eluted at 2%
MeOH and was subsequently concentrated in vacuo.
Acetic anhydride (12 mL) and pyridine (16 mL) were added to the crude dynemicin complex in a 50 mL round-bottomed flask equipped with a magnetic stir bar. The material was stirred at room temperature for ~19 h, during which time it turned from purple/pink to orange.
When complete, the reaction mixture was diluted with ~50 mL EtOAc and washed with ~200 mL H 2 O, followed by 2 x ~150 mL saturated ammonium chloride (NH 4 Cl). The EtOAc was dried over anhyd. Na 2 SO 4 and concentrated in vacuo. Residual acetic anhydride/acetic acid and pyridine were removed by azeotropic distillation with cyclohexane and toluene, if necessary. The acetylated material was purified by flash chromatography on silica gel, with modifications for each compound as described below. If starting material was recovered from the purification, an additional acetylation step was carried out and all acetylated material was combined for the final purification, as described below.
Acetylated material was dissolved in ~20-35% EtOAc in MeOH and loaded onto a 1 x 25 cm Sephadex LH-20 (GE Healthcare Life Sciences) column pre-equilibrated with MeOH. The column was run with MeOH as the mobile phase, and the orange band that eluted was collected and concentrated in vacuo. This material was finally dissolved in 300-500 μL MeOH, and loaded on the same LH-20 column regenerated with MeOH. The column was again run with MeOH as the mobile phase, and the orange material that eluted was collected and concentrated in vacuo yielding pure enediynes as bright orange solids. 1 H and 13 C NMR spectra were recorded in DMSO-d 6 at 400 MHz or 600 MHz, as described below.
Fermentation of M. chersina ΔE10Δorf19 and isolation of compound 7
A mycelial stock of M. chersina ΔE10Δorf19 (50 μL) was plated on medium 53 agar and (sterilized by autoclave) was added to each flask and shaking continued as above.
Cultures were combined and 2 L taken forward for product isolation as described above.
Following workup of the acetylation reaction, the resulting pink-orange oil was purified by flash chromatography on silica gel using a gradient of 50%:50% EtOAc:hexane to 100% EtOAc to 95%:5% EtOAc:MeOH. Orange (acetylated) and pink (unacetylated) fractions were collected separately and concentrated in vacuo. The unreacted starting material was dissolved in 1.5 mL acetic anhydride and 2 mL pyridine and stirred in a 10 mL round-bottomed flask equipped with a magnetic stir bar. After 24 h, the reaction mixture was diluted with ~15 mL EtOAc and washed with ~40 mL H 2 O, followed by 2 x ~40 mL NH 4 Cl. The EtOAc layer was dried over anhyd. 
Fermentation of M. chersina ΔE10 and isolation of compound 10
A mycelial stock of M. chersina ΔE10 (100 μL) was plated on medium 53 agar and Purification of 10 from the fermentations proceeded as described above. After workup of the acetylation reaction, the resulting pink-orange oil was purified by flash chromatography on silica gel using a gradient of 80%:20% EtOAc:hexane to 100% EtOAc to 95%:5% EtOAc:MeOH.
The pink-orange material that eluted at 95%:5% EtOAc:MeOH was collected and concentrated in vacuo. Sephadex LH-20 purification proceeded as described above for the material from the [1- 
Preparation of M. chersina ΔPKS5 spores and isolation of 18 O-labeled 11 from the closedsystem fermentation
The pCRISPR-Cas9 plasmid was eliminated from M. chersina ΔPKS5 by repeated restreaks on medium 53 at 37 o C until replica plating on medium 53 with nalidixic acid and apramycin (20 μg/mL and 50 μg/mL, respectively) produced no growth. Spores of the plasmidfree strain were then prepared by growth on medium 53 for 2-3 weeks, and collected following established protocols 26 . Closed-system fermentation of the ΔPKS5 mutant proceeded as described in the Methods and isolation of triacetyldynemicin A 11 as described above. Following workup of the acetylation reaction, the resulting orange oil was purified by flash chromatography on silica gel using a gradient of 80%:20% EtOAc:hexane to 100% EtOAc to 95%:5% was isolated from the fermentation as described above.
Preparation and purification of triacetyldynemicin A methyl ester 12
Excess diazomethane was added to 11 dissolved in ~200 μL DMSO- orf27  orf21  A4  orf19  E10  A5  O6  T9  T5  T11  T10  A3  orf23  T8  orf24  R10  A2  orf22  orf20  A1  orf26  orf25  E14  E15  R8   E8  U14  R2  orf13  orf17  R3  orf16  orf18  orf14  E13  T3  U15  U6  R7  U16  U8  S6  orf15  U20  U21  E7   orf1  orf13  orf4  orf11  orf2  E12  orf10  orf3  orf5  orf12  orf6  orf8  orf9  E11  orf7   ucmE  orf-2  ucmE4  ucmT1  ucmT2  ucmD  ucmR3  ucmC  orf-1  ucmE5  ucmE3  ucmF  orf-3  ucmR4  ucmE10  ucmS2  ucmS3   ucmG  ucmK1  ucmK2  ucmR2  ucmP  ucmJ  ucmM  ucmB  ucmR7  ucmI  ucmR1  ucmO  orf+1 Table 4 ) was used that annealed to the gDNA in the region flanking the HRT designed for each mutant. PCR amplification of HRTs from the gDNA of all mutant strains produced ~2.2 kb bands that were not produced in PCR reactions from the wild-type gDNA. Note: to ease visualization of data, gel lanes with irrelevant data were removed from images and ladders from the same gel were placed directly next to the lanes of interest. To determine the regiochemistry of A-ring hydroxylation by orf19, we first fully assigned the 1 H NMR spectrum, anticipating its structure to be either 10 or 20 (Supplementary Fig. 6 ). In the fermentation of the ΔE10 mutant that included [1-13 C]-sodium acetate, every other carbon on the enediyne and anthraquinone was labeled as indicated in Fig. 4 . This labeling pattern was anticipated to assist in the assignment of the structure since the two carbons that could be hydroxylated would be differentially labeled. The first indication of the position of the orf19 hydroxyl came from comparison of our 13 C NMR spectrum to that of triacetyldynemicin A. C-15 and C-18 of triacetyldynemicin A have chemical shifts between 145 and 150 ppm; our spectrum lacked labeled carbons between 145 and 150 ppm, suggesting the orf19 hydroxyl was on an unlabeled carbon (i.e. C-18). Looking next at our HSQC spectrum, we reasoned that the 1 H-13 C coupling would be stronger for a labeled carbon. The cross peak signals for H a and H c were both more prominent than that of H b , indicating both were on labeled carbons. This, again, supported orf19 hydroxylation at C-18. Finally, looking at the HMBC spectrum, we saw that the hydrogens on only one of the acetate methyls was detectably coupled to the anthraquinone carbon to which the acetate is attached. That carbon, C-11, is labeled. Collectively, these data led to the assignment of orf19 and E10 as dynemicin C-18-and C-15-hydroxylases, respectively.
Supplementary Figure 18:
Diagram of closed-system fermentation setup. In a 37 o C warm room, oxygen tanks containing 16 O 2 and 18 O 2 were connected through a stopcock to the top of 2 x 1 L pressure-equalizing burets. A three-way valve was positioned between the gas tanks and stopcock to allow venting to the atmosphere. The bottoms of the burets were connected to a 2 L separatory funnel and filled with 10 g/L CuSO 4 -5H 2 O. On the opposite side of the stopcock, 500 mL flasks were connected in series on a shaker. Flasks had 35/25 socket joint openings and were fitted with adapters that allowed gas in and out; the adapters were greased and clamped onto the flasks to ensure a tight seal. The final flask in the series was connected to a gas-washing bottle filled with sterile ddH 2 O, which was positioned before a 2 L side-arm flask filled with a 1.5 L solution of 3 M KOH to trap CO 2 released by the cells. The CO 2 trap was placed atop a magnetic stir plate and stirred constantly throughout the experiment. A modified aquarium pump sealed in glass casing was placed after the trap, which circulated air through a three-way valve back to the flasks. All components of the system were connected by Tygon S3™ Laboratory Tubing, Formulation E-3603. 
